![Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/09/ced-pexels-13091435.jpg?resize=150%2C150&ssl=1 "Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z] 26")
The Realities of Rescheduling Medical Cannabis | Rockefeller Institute of Government
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
The Realities of Cannabis Rescheduling & GMP
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
In the Mix: 11 More Articles — May 15, 2026
This digest reviews 11 cannabis articles clinical relevance from May 15, 2026. The articles cover regulatory enforcement, market trends, and clinical insights. Clinicians will find valuable updates on cannabis research and policy.
Federal Reclassification Reshapes Risks for Medical Marijuana Businesses
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustrySafety Why This Matters Federal reclassification of cannabis from Schedule I to Schedule III creates…
The Trump administration’s moves on marijuana and psychedelics signal the start of a new …
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchMental Health Clinical Summary I don’t have access to the full article content needed to write an…
White House drug czar says cannabis is “still illegal” after rescheduling (Newsletter: May 11, 2026)
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchAgingMental Health Why This Matters Clinicians need to understand that despite the DEA’s…
US Federal Policy on Medical Cannabis Rescheduling: A Step Forward with Remaining …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchSafety Why This Matters Federal rescheduling of cannabis could legitimize prescribing practices that…
White House Drug Czar Clarifies That Marijuana Is ‘Still Illegal’ Following Trump …
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempTHC Why This Matters Clinicians need to understand that federal recriminalization of hemp-derived THC products…
Congress considers veterans’ medical cannabis amendment (Newsletter: May 8, 2026)
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyMental HealthResearchSafety Why This Matters If Congress passes a veterans’ medical cannabis amendment, it…
DEA Reiterates Stance That Lab-Derived Cannabinoids Are Not Compliant With the Farm Bill
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchHempIndustry Why This Matters Clinicians need to understand that synthetic cannabinoids derived from…